RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• RAS family small GTPases are crucial for neuronal survival, growth, and differentiation in postmitotic neurons.
• Dysregulation of RAS signaling or its downstream RAF-MEK-ERK pathway is implicated in RASopathies, a group of neurodevelopmental disorders.
• The precise pathogenic mechanisms of RASopathies are an active area of research.

Purpose of the Study:

• To summarize the in vivo functions of RAS-RAF-MEK-ERK signaling in neurons.
• To explore therapeutic perspectives for utilizing this pathway in treating nervous system injury and RASopathies.
• To discuss potential applications for other neurological conditions.

Main Methods:

• Review and synthesis of existing literature on RAS-RAF-MEK-ERK signaling in neuronal function.
• Analysis of in vivo studies investigating the role of this pathway in neuronal development and disease.
• Discussion of translational research and therapeutic strategies.

Main Results:

• RAS-RAF-MEK-ERK signaling is essential for normal neuronal development and function.
• Aberrant signaling in this pathway leads to neurodevelopmental deficits characteristic of RASopathies.
• The pathway's role in neuronal plasticity and response to injury is highlighted.

Conclusions:

• The RAS-RAF-MEK-ERK pathway is a critical regulator of neuronal health and function.
• Targeting this pathway holds promise for developing novel treatments for RASopathies and neurological injuries.
• Further research into this signaling cascade could uncover new therapeutic avenues for diverse neurological conditions.